Adverse drug reactions of itolizumab in COVID-19 patient : A case report
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:54 |
|---|---|
| Enthalten in: |
Indian journal of pharmacology - 54(2022), 5 vom: 20. Sept., Seite 377-378 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mohammed, Ziauddin [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Monoclonal |
|---|
| Anmerkungen: |
Date Completed 21.12.2022 Date Revised 20.06.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.4103/ijp.ijp_803_21 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM350491933 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM350491933 | ||
| 003 | DE-627 | ||
| 005 | 20231226045125.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4103/ijp.ijp_803_21 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1168.xml |
| 035 | |a (DE-627)NLM350491933 | ||
| 035 | |a (NLM)36537408 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mohammed, Ziauddin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Adverse drug reactions of itolizumab in COVID-19 patient |b A case report |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.12.2022 | ||
| 500 | |a Date Revised 20.06.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Letter | |
| 650 | 7 | |a itolizumab |2 NLM | |
| 650 | 7 | |a XQQ2RHV14N |2 NLM | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a Antibodies, Monoclonal |2 NLM | |
| 700 | 1 | |a Suryachandra, Kandi |e verfasserin |4 aut | |
| 700 | 1 | |a Dandekar, Manoj P |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Indian journal of pharmacology |d 1982 |g 54(2022), 5 vom: 20. Sept., Seite 377-378 |w (DE-627)NLM078779812 |x 1998-3751 |7 nnns |
| 773 | 1 | 8 | |g volume:54 |g year:2022 |g number:5 |g day:20 |g month:09 |g pages:377-378 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4103/ijp.ijp_803_21 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 54 |j 2022 |e 5 |b 20 |c 09 |h 377-378 | ||